Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Zhongguo Shi Yan Xue Ye Xue Za Zhi|December 22, 2012
[Role of Lyn kinase in imatinib-resistant chronic myelogenous leukemia]Juan Liu, Xie-Lan Zhao
Hunan Yi Ke Da Xue Xue Bao = Hunan Yike Daxue Xuebao = Bulletin of Hunan Medical University|December 5, 2003
[Clinical analysis of 282 patients with non-Hodgkin's lymphoma]Shu-ping Chen, Deng-shu Wu, Xie-lan Zhao
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 24, 2005
[Inhibitory effect of daunorubicin enhanced by PDTC on drug-resistant leukemic cells in vitro]Hu-Yi Lei, Xie-Lan Zhao, Xi-Bin Xiao
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 28, 2006
[Renin angiotensin system in bone marrow of patients with aplastic anemia]Min-Yuan Peng, Xie-Lan Zhao, Xin Gao, et al.
The Kaohsiung Journal of Medical Sciences|August 13, 2020
Chidamide acts on the histone deacetylase-mediated miR-34a/Bcl-2 axis to regulate NB4 cell line proliferation and apoptosisJie Peng, Shu-Jun Li, Xiao Fu, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|July 6, 2007
[Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia]Ya-jing Xu, Fang-ping Chen, Xiao-lin Li, et al.
Medical Hypotheses|August 25, 2009
Hypothesizing that histone deacetylase inhibitors can be used to reverse multiple drug resistanceZhi-Ping Jiang, Ping Xu, Guan-Ping Wang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 2, 2011
[Expression of DNA-dependent protein kinase catalytic subunit in adult acute leukemia and its significance]Rui Shen, Xie-Lan Zhao, Zhao Ouyang, et al.
Pharmacogenomics|December 20, 2016
Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysisZhi-Ping Jiang, Xie-Lan Zhao, Naoto Takahashi, et al.
Pageof 4